Analysis of Blood Components and Target Prediction for the Combined Use of <i>Dendrobium officinale</i> Compound and Western Medicine in Antihypertensive Therapy Based on Network Pharmacology and Molecular Docking.

Drug Des Devel Ther · 2025 · PMC12357559 · PMID 40822384

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Therefore, we propose that PA, KF, and RU are likely to be significant contributors to the therapeutic efficacy of DOC.

also in 484 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Analysis of Blood Components and Target Prediction for the Combined Use of &lt;i&gt;Dendrobium officinale&lt;/i&gt; Compound and Western Medicine in Antihypertensive Therapy Based on Network Pharmacology and Molecular Docking.

The sentences

Analysis of Blood Components and Target Prediction for the Combined Use of <i>Dendrobium officinale</i> Compound and Western Medicine in Antihypertensive Therapy Based on Network Pharmacology and Molecular Docking.